These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3437069)

  • 1. Pharmacodynamics of triazolam after intravenous administration.
    Smith RB; Kroboth PD; Varner PD
    J Clin Pharmacol; 1987 Dec; 27(12):971-9. PubMed ID: 3437069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal variation in triazolam pharmacokinetics and pharmacodynamics after oral administration.
    Smith RB; Kroboth PD; Phillips JP
    J Clin Pharmacol; 1986 Feb; 26(2):120-4. PubMed ID: 3950055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity to triazolam in the elderly.
    Greenblatt DJ; Harmatz JS; Shapiro L; Engelhardt N; Gouthro TA; Shader RI
    N Engl J Med; 1991 Jun; 324(24):1691-8. PubMed ID: 2034245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troleandomycin-triazolam interaction in healthy volunteers: pharmacokinetic and psychometric evaluation.
    Warot D; Bergougnan L; Lamiable D; Berlin I; Bensimon G; Danjou P; Puech AJ
    Eur J Clin Pharmacol; 1987; 32(4):389-93. PubMed ID: 3497041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of zopiclone, triazolam and placebo on memory and psychomotor performance in healthy volunteers.
    Warot D; Bensimon G; Danjou P; Puech AJ
    Fundam Clin Pharmacol; 1987; 1(2):145-52. PubMed ID: 3679064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of triazolam after two intermittent doses in obese and normal-weight men.
    Derry CL; Kroboth PD; Pittenger AL; Kroboth FJ; Corey SE; Smith RB
    J Clin Psychopharmacol; 1995 Jun; 15(3):197-205. PubMed ID: 7635997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory and sedative effects of triazolam in volunteers.
    Longbottom RT; Pleuvry BJ
    Br J Anaesth; 1984 Feb; 56(2):179-85. PubMed ID: 6140935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nighttime dosing of triazolam in patients with liver disease and normal subjects: kinetics and daytime effects.
    Kroboth PD; Smith RB; Van Thiel DH; Juhl RP
    J Clin Pharmacol; 1987 Aug; 27(8):555-60. PubMed ID: 3655006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute tolerance to triazolam during continuous and step infusions: estimation of the effect offset rate constant.
    Kroboth PD; Bertz RJ; Smith RB
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1047-55. PubMed ID: 8450449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing a benzodiazepine agonist (triazolam) from a nonagonist anxiolytic (buspirone) by electroencephalography: kinetic-dynamic studies.
    Greenblatt DJ; Harmatz JS; Gouthro TA; Locke J; Shader RI
    Clin Pharmacol Ther; 1994 Jul; 56(1):100-11. PubMed ID: 8033487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triazolam-amphetamine interaction: dissociation of effects on memory versus arousal.
    Mintzer MZ; Griffiths RR
    J Psychopharmacol; 2003 Mar; 17(1):17-29. PubMed ID: 12680736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of oral triazolam and nitrous oxide with placebo and intravenous diazepam for outpatient premedication.
    Kaufman E; Hargreaves KM; Dionne RA
    Oral Surg Oral Med Oral Pathol; 1993 Feb; 75(2):156-64. PubMed ID: 8426714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and pharmacodynamic evaluation of novel dual release formulations of triazolam.
    Smith RB; Kroboth PD; Folan MM; Kroboth FJ; Rosanske TW
    Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):422-9. PubMed ID: 8225690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. II. Triazolam.
    Gupta SK; Ellinwood EH; Nikaido AM; Heatherly DG
    Pharm Res; 1990 Jun; 7(6):570-6. PubMed ID: 2367325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects.
    Berlin I; Warot D; Hergueta T; Molinier P; Bagot C; Puech AJ
    J Clin Psychopharmacol; 1993 Apr; 13(2):100-6. PubMed ID: 8463441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated administration of diazepam and triazolam to subjects with histories of drug abuse.
    Roache JD; Griffiths RR
    Drug Alcohol Depend; 1986 May; 17(1):15-29. PubMed ID: 3720528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychophysiological effects and dose equivalence of zopiclone and triazolam administered to healthy volunteers. Methodological considerations.
    Gorenstein C; Tavares SM; Gentil V; Peres C; Moreno RA; Dreyfus JF
    Braz J Med Biol Res; 1990; 23(10):941-51. PubMed ID: 2101059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response evaluation of the amnestic effects of triazolam and pentobarbital in normal subjects.
    Kirk T; Roache JD; Griffiths RR
    J Clin Psychopharmacol; 1990 Jun; 10(3):160-7. PubMed ID: 2198294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of methylprednisolone on CYP3A4-mediated drug metabolism in vivo.
    Villikka K; Varis T; Backman JT; Neuvonen PJ; Kivistö KT
    Eur J Clin Pharmacol; 2001 Sep; 57(6-7):457-60. PubMed ID: 11699609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triazolam pharmacokinetics after intravenous, oral, and sublingual administration.
    Kroboth PD; McAuley JW; Kroboth FJ; Bertz RJ; Smith RB
    J Clin Psychopharmacol; 1995 Aug; 15(4):259-62. PubMed ID: 7593708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.